(Q42253380)

19 October 2017

Expression of Ku86 and presence of Ku86 antibody as biomarkers of hepatitis B virus related hepatocellular carcinoma (English)

1 reference

19 October 2017

0 references

1 reference

Yong Xu

1

1 reference

19 October 2017

Ai-Jun Liu

2

1 reference

19 October 2017

Yuan-Xing Gao

3

1 reference

19 October 2017

Ming-Gen Hu

4

1 reference

19 October 2017

Guo-Dong Zhao

5

1 reference

19 October 2017

Zhi-Ming Zhao

6

1 reference

19 October 2017

Rong Liu

7

1 reference

19 October 2017

24 November 2013

1 reference

Digestive Diseases and Sciences

19 October 2017

1 reference

19 October 2017

59

1 reference

19 October 2017

3

1 reference

19 October 2017

614-622

1 reference

https://scigraph.springernature.com/pub.10.1007/s10620-013-2941-1

19 October 2017

0 references

cites work

FOXP3 gene polymorphism is associated with hepatitis B-related hepatocellular carcinoma in China

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2941-1

Imaging of early hepatocellular carcinoma and adenomatous hyperplasia (dysplastic nodules) with dynamic ct and a combination of CT and angiography: experience with resected liver specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2941-1

Qualitative and quantitative evaluation of hepatocellular carcinoma and cirrhotic liver enhancement using Gd-EOB-DTPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2941-1

Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2941-1

The association of DNA-dependent protein kinase activity of peripheral blood lymphocytes with prognosis of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2941-1

Replication independent DNA double-strand break retention may prevent genomic instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2941-1

Expression of Ku70 and Ku80 mediated by NF-kappa B and cyclooxygenase-2 is related to proliferation of human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2941-1

Serum anti-Ku86 is a potential biomarker for early detection of hepatitis C virus-related hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2941-1

Secretory/releasing proteome-based identification of plasma biomarkers in HBV-associated hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2941-1

DNA repair biomarker profiling of head and neck cancer: Ku80 expression predicts locoregional failure and death following radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2941-1

Ku86 is important for TrkA overexpression-induced breast cancer cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2941-1

Autoantibodies to tailor-made panels of tumor-associated antigens in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2941-1

Unbalanced oxidant-induced DNA damage and repair in COPD: a link towards lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-013-2941-1

T cell-dependent antibody responses against aberrantly expressed cyclin B1 protein in patients with cancer and premalignant disease

21 January 2018

1 reference

12 December 2020

Hepatocellular carcinoma: natural history, current management, and emerging tools

1 reference

12 December 2020

Synergistic role of Ku80 and poly(ADP-ribose) polymerase in suppressing chromosomal aberrations and liver cancer formation

1 reference

12 December 2020

Tissue polypeptide specific antigen as a marker used to determine the liver diseases

1 reference

12 December 2020

Des-γ-carboxy prothrombin ratio measured by P-11 and P-16 antibodies is a novel biomarker for hepatocellular carcinoma

1 reference

12 December 2020

The clinical value of hepatocyte growth factor and its receptor--c-met for liver cancer patients with hepatectomy

1 reference

12 December 2020

Analysis and results of Ku and XRCC4 expression in hypopharyngeal cancer tissues treated with chemoradiotherapy

1 reference

12 December 2020

10.1007/S10620-013-2941-1

Identifiers

DOI

1 reference

19 October 2017

1 reference